Showing results (141-150 of 3,155) with videos related to
Sort By:
Pageof 316
Translational Oncology|February 22, 2021
Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional studyChenyan Guo, Jue Wang, Yongming Wang, et al.Translational Oncology|February 22, 2021
Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgeryYa-Hua Wu, Ming-Qiang Lin, Zhi-Ping Wang, et al.Translational Oncology|April 22, 2017
Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung CancerPeng Kuang, Zuhua Chen, JiaYuan Wang, et al.Translational Oncology|March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent CohortsDanijel Sikic, Ralph M Wirtz, Sven Wach, et al.Translational Oncology|November 6, 2018
Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAMDaisuke Kyuno, Kun Zhao, Nathalie Bauer, et al.Translational Oncology|December 13, 2021
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic reviewGwen Schroyen, Julie Vissers, Ann Smeets, et al.Translational Oncology|December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancerR Nicolle, O Gayet, M Bigonnet, et al.Translational Oncology|December 17, 2021
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltrationDan Xiong, Mojuan Li, Chong ZengTranslational Oncology|November 4, 2021
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancerShayan Khalafi, Shoumin Zhu, Rimpi Khurana, et al.Translational Oncology|November 11, 2021
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfallsA Franza, M Claps, G ProcopioPageof 316